Toxic epidermal necrolysis.
- Hoetzenecker W Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.
- Mehra T Medical Directorate, University Hospital of Zürich, Zürich, Switzerland.
- Saulite I Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland; Riga Stradins University, Riga, Latvia.
- Glatz M Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.
- Schmid-Grendelmeier P Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.
- Guenova E Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.
- Cozzio A Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.
- French LE Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.
- 2016-05-31
Published in:
- F1000Research. - 2016
English
Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug-induced skin disease with a mortality rate of approximately 30%. The clinical hallmark of TEN is a marked skin detachment caused by extensive keratinocyte cell death associated with mucosal involvement. The exact pathogenic mechanism of TEN is still uncertain. Recent advances in this field have led to the identification of several factors that might contribute to the induction of excessive apoptosis of keratinocytes. In addition, specific human leukocyte antigen types seem to be associated with certain drugs and the development of TEN. As well-controlled studies are lacking, patients are treated with various immunomodulators (e.g. intravenous immunoglobulin) in addition to the best supportive care.
- Language
-
- English
- Open access status
- gold
- Identifiers
-
- DOI 10.12688/f1000research.7574.1
- PMID 27239294
- Persistent URL
- https://sonar.ch/global/documents/255555
Statistics
Document views: 31
File downloads:
- Full-text: 0